Substance Use Disorder

A discussion of treatment options to help foster the most effective psychosocial treatment for addiction.

There are probably few health care professionals who are unaware of the concerns about the apparent overprescription of opioids. However, we have had only limited information on how good a job physicians may actually be doing in prescribing these medications.

The authors use a 3-step process to identify and evaluate published research with findings that are ready for-and that have a direct bearing on-clinical practice.

There is increasing evidence that individuals who try marijuana during their early teenage years are affected neurologically for a decade or more at least until one's 20s and perhaps even longer. More in this video.

In clinical terms, one of the most distinguishing diagnostic features of addictive disorders is that those affected continually and repeatedly revert to their addictive behaviors, despite the devastating negative and adverse consequences.

Is your older patient using or abusing drugs or alcohol? This video reviews how general psychiatrists can provide effective intervention when a substance abuse problem is identified.

Given the pervasiveness of substance use disorders, the information provided here is relevant not only for addiction psychiatrists, but all mental health providers and primary care physicians.

This brief communication highlights clinically applicable information and take-home points presented at the American Academy of Addiction Psychiatry Annual Meeting.

Medication misuse and alcohol abuse are a huge problem in the US, and women and the elderly are not exempt. In this Q&A, an expert touches on the epidemiology, recognition, assessment, and treatment of substance use disorder in these two populations.

Because at least 10% of the US population suffers from a substance use disorder in any given year, the American Academy of Addiction Psychiatry has expanded its longstanding Board Review Course in Addictions to a more inclusive “Addictions and Their Treatment” course.

An overview of select topics in clinical psycho-oncology, including assessment and management of delirium and brain lesions, mood and anxiety disorders, medication adverse effects, and existential death anxiety.

The use of buprenorphine for the treatment of opioid dependence is on the rise. However, buprenorphine withdrawal has its own withdrawal symptoms that in many cases can be as severe as symptoms of opioid withdrawal.

In a world in which substance use disorders are no longer suffered in isolation, treating addiction is a challenging journey with obstacles, intermittent failures, and life-altering successes. A poem on drug withdrawal expressed through the eyes of a fellow in addiction medicine.

A guide for helping patients understand heroin, its history, and how it impacts our communities.

Severe alcohol dependence and frequent relapses in this patient prompts his son to produce a durable power of attorney for health care. He demands that the physicians declare his father to lack decision-making capacity. More in this ethics case report.

There is increasing evidence and support for medications for alcohol use disorders to be used in regular clinical practice, and not to be limited to specialty substance abuse settings. Here, special considerations for pharmacological management.

In the US, 38,000 drug overdose deaths occur per year, and it is estimated that 75% are opioid-related. The good news is that addiction is a treatable disease. More in this discussion of opioid addiction, the use of naloxone, and Good Samaritan laws.

Clinicians will be drawn in by author Charles R. Cross's personal experience documenting, Here We Are Now: The Lasting Impact of Kurt Cobain. Cobain, lead singer of Nirvana, committed suicide 20 years ago this month.

What expanded roles should psychiatrists be playing in the provision of proper pain management without taking their eyes off the issue of prescription opioid misuse and abuse? Insights here.

Alcohol misuse in older adults is often underdiagnosed in medical practice. This age group is rapidly moving into the treatment realm of the practicing general, geriatric, and addiction psychiatrist.

Substance abuse and addiction are commonly associated with an increased risk of suicide. Alcohol abuse plays a key role in suicide attempts and completions; prescription drugs are a close second. The causes of suicide for men and women are different but the suicide rates are equally staggering.

What medications are FDA approved for alcohol dependence? Take the quiz and learn more.

Many barriers can prevent physicians who have a substance use disorder from obtaining the help they need. However, in many states, all is not lost for physicians who willingly participate in treatment. Here, signs, symptoms, and intervention steps.

This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.

Stopping smoking affects the metabolism of a number of drugs used in the management of mental illness. Here, a summary of the author's published study on whether e-cigarettes with nicotine were more effective for smoking cessation than nicotine patches.

Smoking is the leading cause of preventable morbidity and mortality in the US. The majority of smokers want to quit, but only a fraction achieve this annually. New evidence shows it is possible to teach patients to weaken the link between craving and smoking until they are able to ride out any craving–and consequently quit.

What percentage of patients with schizophrenia have a comorbid cannabis use disorder? Take the quiz and learn more.

Psychiatrists are urged to familiarize themselves with these new drugs and the typical presentations of patients who use them since implications of misdiagnosis can be far-reaching.

The challenges of identifying patients at risk for alcohol withdrawal have been found to be mitigated by the development of a Risk Stratification Questionnaire, now being adopted by the VA regionally throughout New England. More in this video.

The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.